TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
ARCT

Arcturus Therapeutics Holdings Inc

Healthcare · Biotechnology

13.30$ -7.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Arcturus Therapeutics Holdings Inc (ARCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 224 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARCT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
458 429 419 389 371 344 332 309 282 271 245 224
393 387 376 347 331 306 279 275 249 241 217 197
312 292 288 315 237 237 217 196 180 231 211 191
312 292 288 315 237 237 217 196 180 231 211 191
38 32 27 24 30 4.0 15 17 8.0 5.6 1.3 1.8
35 0.0 55 0.0
178 151 155 130 109 103 98 78 58 57 54 53
88 82 115 92 69 65 49 47 32 36 34 34
4.2 4.3 4.3 3.9 3.4 3.6 3.7 4.0 4.1 4.2 4.3 4.0
18 5.3 9.1 14 10 7.2 6.2 11 5.5 4.2 4.1 4.4
20 15
280 279 264 259 262 241 234 231 225 214 191 172
-356 -368 -395 -412 -419 -449 -463 -472 -486 -515 -542 -565
27 27 27 27 27 27 27 27 27 27 28 28

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?